Today’s pharma innovators face growing complexity across therapeutic modalities, development timelines, regulatory demands, and supply chain resilience. Success requires a partner with the right expertise, capabilities, and agility.
Aragen delivers end-to-end CRDMO solutions for small molecules, biologics, peptides, oligonucleotides, ADCs, and next-generation therapeutics. Our integrated discovery, development, manufacturing, and analytical capabilities ensure a seamless path from early research to commercial supply, reducing risk and accelerating time to market.
Powered by deep scientific expertise, advanced infrastructure, and Digital & AI-enabled insights, we deliver with a steadfast commitment to quality, sustainability, and supply chain resilience to bring life-changing therapies to patients faster.
Successful small molecule programs demand scalable processes, reliable manufacturing, integrated formulation development, and analytical excellence. Aragen supports customers across the entire development continuum—from route selection and process optimization to seamless tech transfer, analytical development, clinical supply, commercial manufacturing, and lifecycle management.
Biologics development requires seamless alignment across cell line development, process characterization, analytical development, manufacturing scale-up, tech transfer, and regulatory readiness. Aragen’s integrated biologics platform supports monoclonal antibodies, biosimilars, bispecifics, and other complex biologics—minimizing complexity and maintaining quality, scalability, and speed throughout development.
Supporting the next generation of therapeutics through specialized scientific expertise and scalable development strategies
From early development to manufacturing support, leveraging expertise in phosphoramidite chemistry, process optimization, analytical characterization, and scalable production.
Integrated solutions for peptide development, scale-up, analytical support, and manufacturing.
Support for payloads, linkers, and complex chemistries through dedicated scientific teams and high-containment infrastructure.
Capabilities supporting advanced biologics, targeted therapies, and other emerging therapeutic platforms.
At Aragen, supply chain resilience is powered by diversification, localization, digitalization, and operational excellence—helping ensure your molecules reach patients reliably, efficiently, and responsibly.
Hyper-Local & Diversified Sourcing
Sustainability at the Core
Digitally-Driven Efficiency
Global Coordination Advantage
Integrated CRDMO Model. Fewer Handoffs. Greater Continuity.
From discovery through commercial manufacturing, Aragen brings together discovery, development, manufacturing, and analytical services under one roof—reducing complexity, minimizing technology transfer risks, and improving program continuity.
Expertise Across Molecules and Modalities
Deep scientific expertise spanning small molecules, biologics, peptides, oligonucleotides, ADCs, high-potency compounds, and complex chemistries enables customers to advance diverse pipelines with confidence.
Built to Scale with Your Program
Flexible capabilities support every stage of development—from early discovery and clinical development to commercial manufacturing and lifecycle management.
Quality and Compliance Built into Every Stage
Robust quality systems, regulatory readiness, and a strong culture of operational excellence underpin development and manufacturing activities across our global network.
Global Infrastructure, Collaborative Execution
Integrated scientific teams, GMP manufacturing facilities, and supply chain capabilities across geographies provide the flexibility, reliability, and responsiveness needed to support global development programs.
Customer-Centric Partnerships
Flexible engagement models and dedicated project teams aligned to your scientific, operational, and strategic objectives
Comprehensive small molecule development and manufacturing solutions supporting programs from discovery through commercialization.
Talk to Our Small Molecule Experts
Let’s discuss how to create a development and manufacturing strategy that supports your molecule from process design through commercial launch.
Integrated biologics discovery, development, manufacturing, and analytical solutions designed to enable next-generation therapies.
Talk to Our Biologics Experts
Whether you’re developing a monoclonal antibody, biosimilar, bispecific, fusion protein, or emerging biologic modality, Aragen can help establish a development and manufacturing pathway designed for scalability, quality, and long-term supply success.
Meet our team of experts who will be present at CPHI Milan 2026.
Connect with us to discuss your drug development challenges.
